Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Robert Bosch Hospital · KU Leuven · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
112
total citations
- FWCI
- 109.15
- Percentile
- 100%
- References
- 205
Citations per year
Authors
69Topics & keywords
Topics
Keywords
- Kidney disease
- Medicine
- Disease
- Kidney
- Bone disease
- Internal medicine
- Intensive care medicine
- Osteoporosis
No related works found for this paper.
Funding
- KDKidney Disease: Improving Global Outcomes
- ASAmerican Society of Nephrology
- AAmgen
- AAstraZeneca
- APAlexion Pharmaceuticals
- UOUniversity of Pennsylvania
- HKHong Kong Society of Nephrology
- VPVertex Pharmaceuticals
- ATAmicus Therapeutics
- FMFresenius Medical Care North America
- OHOPKO Health
- KKissei
- TPTorii Pharmaceutical
- IPInozyme Pharma
- ECEuropean Commission
- NNierstichting
- CNConselho Nacional de Desenvolvimento Científico e Tecnológico
- APAstellas Pharma
- IOInternational Osteoporosis Foundation
- OPOno Pharmaceutical
- KSKorean Society of Nephrology
- MGMenarini Group
- IPIntas Pharmaceuticals
- NINational Institutes of Health
- NHNational Heart, Lung, and Blood Institute
- NINational Institute of Diabetes and Digestive and Kidney Diseases